OTC Healthcare in Belarus
Euromonitor International's OTC Healthcare in Belarus market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 100 | Publication date: Sep 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Rising incomes boost self-medication
The Belarusian OTC healthcare market continued to show stable growth in 2007. Growth was higher than in 2006 due to consumers’ rising disposable income and growing awareness among the population regarding the main drugs. Overall, per capita spending on OTC and Rx drugs in 2007 in Belarus was just under US$50.00. With busier lifestyles in Belarus, particularly among urban consumers, OTC medicines’ growth was also driven by the increasing popularity of self medication as being more convenient and less time consuming than spending long hours in public clinics. Increasing advertising campaigns the main players also boosted the popularity of self-medicating.
Generics remain predominant on Belarusian market
The key trend on the Belarusian market in 2007 was the still dominant position of generic drugs in terms of their market share, while branded drugs having a lower priority. The shares held by generics and branded products in value terms in 2007 remained at 75% and 25% respectively. With genetics sharing 75% in the market in 2007, they will remain the most popular in the nearest future, but their market share is more likely decline over the forecast period.
Market is driven by imported products
The Belarusian pharmaceuticals environment is predominantly driven by imported medicines from large multinational companies, which are supported by major advertising campaigns. Advertising is a primary key to success on the Belarusian OTC healthcare market, and a wide range of multinational companies benefit from that. Among the 10 leading pharmaceutical companies in 2007, eight were multinationals. Two companies among the top 10 were local manufacturers – Borisov Medical Preparations Plant and Belmedpreparaty – which held second and fourth places in value terms in 2007. The Belarusian Government has announced a plan to replace imported products with locally produced alternatives. As part of this, locally produced goods will be highly supported and subsidised.
Distribution limitations a key factor
The government in Belarus maintains a firm grip on the distribution of all pharmaceutical goods, including OTC products, with sales allowed only through chemists. No OTC products are available through other channels, such as supermarkets, hypermarkets, via the Internet or by direct sale.
Good opportunities for growth
The Belarusian pharmaceuticals industry has a promising future. The OTC healthcare market in Belarus has potential for growth developing in value terms rather than volume due to consumers increasingly switching to more expensive drugs. Carrying out the programme of “producing import replacing products”, the state will support national manufacturers as well as their products. This is likely to result in the fact that most Belarusian producers will occupy low price/quality niches, while foreign producers will offer more expensive and premium products.
Table of contents
OTC HEALTHCARE IN BELARUS : MARKET INSIGHT
EXECUTIVE SUMMARY
Rising incomes boost self-medication
Generics remain predominant on Belarusian market
Market is driven by imported products
Distribution limitations a key factor
Good opportunities for growth
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
Table 2 Life Expectancy at Birth 2002-2007
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
Table 5 OTC Healthcare Company Shares by Value 2003-2007
Table 6 OTC Healthcare Brand Shares by Value 2004-2007
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
APPENDIX
OTC Registration and Classification
De-listing or De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
Generics
DEFINITIONS
ANALGESICS
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of Analgesics by Subsector: Value 2002-2007
Table 12 Sales of Analgesics by Subsector: % Value Growth 2002-2007
Table 13 Analgesics Company Shares by Value 2003-2007
Table 14 Analgesics Brand Shares by Value 2004-2007
Table 15 Forecast Sales of Analgesics by Subsector: Value 2007-2012
Table 16 Forecast Sales of Analgesics by Subsector: % Value Growth 2007-2012
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2002-2007
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2002-2007
Table 19 Sales of Decongestants by Type: Value 2002-2007
Table 20 Sales of Decongestants by Type: % Value Growth 2002-2007
Table 21 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2002-2007
Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2002-2007
Table 23 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2003-2007
Table 24 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2004-2007
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2007-2012
Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2007-2012
DIGESTIVE REMEDIES
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 27 Sales of Digestive Remedies by Subsector: Value 2002-2007
Table 28 Sales of Digestive Remedies by Subsector: % Value Growth 2002-2007
Table 29 Digestive Remedies Company Shares by Value 2003-2007
Table 30 Digestive Remedies Brand Shares by Value 2004-2007
Table 31 Forecast Sales of Digestive Remedies by Subsector: Value 2007-2012
Table 32 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2007-2012
MEDICATED SKIN CARE
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 33 Sales of Medicated Skin Care by Subsector: Value 2002-2007
Table 34 Sales of Medicated Skin Care by Subsector: % Value Growth 2002-2007
Table 35 Medicated Skin Care Company Shares by Value 2003-2007
Table 36 Medicated Skin Care Brand Shares by Value 2004-2007
Table 37 Hair Loss Treatments Brand Shares by Value 2004-2007
Table 38 Forecast Sales of Medicated Skin Care by Subsector: Value 2007-2012
Table 39 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2007-2012
VITAMINS AND DIETARY SUPPLEMENTS
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 40 Sales of Vitamins and Dietary Supplements by Subsector: Value 2002-2007
Table 41 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2002-2007
Table 42 Sales of Vitamins by Type: Value 2002-2007
Table 43 Sales of Vitamins by Type: % Value Growth 2002-2007
Table 44 Sales of Dietary Supplements by Type: Value 2002-2007
Table 45 Sales of Dietary Supplements by Type: % Value Growth 2002-2007
Table 46 Vitamins and Dietary Supplements Company Shares by Value 2003-2007
Table 47 Vitamins and Dietary Supplements Brand Shares by Value 2004-2007
Table 48 Vitamins Brand Shares by Value 2004-2007
Table 49 Dietary Supplements Brand Shares by Value 2004-2007
Table 50 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2007-2012
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2007-2012
NRT SMOKING CESSATION AIDS
Headlines
Trends
Competitive Landscape
Prospects
Sector Indicators
Table 52 Number of Smokers by Gender 2002-2007
Sector Data
Table 53 Sales of Smoking Cessation Aids by Subsector: Value 2002-2007
Table 54 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2002-2007
Table 55 Smoking Cessation Aids Company Shares by Value 2003-2007
Table 56 Smoking Cessation Aids Brand Shares by Value 2004-2007
Table 57 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2007-2012
Table 58 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2007-2012
EYE CARE
Headlines
Sector Data
Table 59 Sales of Eye Care by Subsector: Value 2002-2007
Table 60 Sales of Eye Care by Subsector: % Value Growth 2002-2007
Table 61 Eye Care Company Shares by Value 2003-2007
Table 62 Eye Care Brand Shares by Value 2004-2007
Table 63 Forecast Sales of Eye Care by Subsector: Value 2007-2012
Table 64 Forecast Sales of Eye Care by Subsector: % Value Growth 2007-2012
WOUND TREATMENTS
Headlines
Sector Data
Table 65 Sales of Wound Treatments by Subsector: Value 2002-2007
Table 66 Sales of Wound Treatments by Subsector: % Value Growth 2002-2007
Table 67 Wound Treatments Company Shares by Value 2003-2007
Table 68 Wound Treatments Brand Shares by Value 2004-2007
Table 69 Forecast Sales of Wound Treatments by Subsector: Value 2007-2012
Table 70 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2007-2012
EAR CARE
Headlines
Sector Data
Table 71 Sales of Ear Care: Value 2002-2007
Table 72 Sales of Ear Care: % Value Growth 2002-2007
Table 73 Ear Care Company Shares by Value 2003-2007
Table 74 Ear Care Brand Shares by Value 2004-2007
Table 75 Forecast Sales of Ear Care: Value 2007-2012
Table 76 Forecast Sales of Ear Care: % Value Growth 2007-2012
ADULT MOUTH CARE
Headlines
Sector Data
Table 77 Sales of Adult Mouth Care: Value 2002-2007
Table 78 Sales of Adult Mouth Care: % Value Growth 2002-2007
Table 79 Adult Mouth Care Company Shares by Value 2003-2007
Table 80 Adult Mouth Care Brand Shares by Value 2004-2007
Table 81 Forecast Sales of Adult Mouth Care: Value 2007-2012
Table 82 Forecast Sales of Adult Mouth Care: % Value Growth 2007-2012
CALMING AND SLEEPING PRODUCTS
Headlines
Sector Data
Table 83 Sales of Calming and Sleeping Products: Value 2002-2007
Table 84 Sales of Calming and Sleeping Products: % Value Growth 2002-2007
Table 85 Calming and Sleeping Products Company Shares by Value 2003-2007
Table 86 Calming and Sleeping Products Brand Shares by Value 2004-2007
Table 87 Forecast Sales of Calming and Sleeping Products: Value 2007-2012
Table 88 Forecast Sales of Calming and Sleeping Products: % Value Growth 2007-2012
EMERGENCY CONTRACEPTION
Headlines
Sector Data
Table 89 Sales of Emergency Contraception: Value 2002-2007
Table 90 Sales of Emergency Contraception: % Value Growth 2002-2007
Table 91 Forecast Sales of Emergency Contraception: Value 2007-2012
Table 92 Forecast Sales of Emergency Contraception: % Value Growth 2007-2012
BELMEDPREPARATY RUE
Strategic Direction
Key Facts
Summary 1 Belmedpreparaty RUE: Key Facts
Summary 2 Belmedpreparaty RUE: Operational Indicators
Company Background
Production
Summary 3 Belmedpreparaty RUE: Production Statistics 2007
Competitive Positioning
Summary 4 Belmedpreparaty RUE: Competitive Position 2007
BORISOV PLANT OF MEDICAL PREPARATIONS
Strategic Direction
Key Facts
Summary 5 Borisov Plant of Medical Preparations: Key Facts
Summary 6 Borisov Plant of Medical Preparations: Operational Indicators
Company Background
Production
Summary 7 Borisov Plant of Medical Preparations: Production Statistics 2007
Competitive Positioning
Summary 8 Borisov Plant of Medical Preparations: Competitive Position 2007